36 results
P
deficient 25(OH)D levels
I/C
serum 25-hydroxyvitamin D (25[OH]D), non-deficient 25(OH)D levels
O
TMD incidence
P
Robotic Hepatectomy (RH), Laparoscopic Hepatectomy (LH), Open Hepatectomy (OH)
I/C
RH, LH, RH vs LH, RH vs OH, LH vs OH
O
Cost-effectiveness, Survival benefits, Estimated blood loss, Major morbidity rate, Length of stay, Operative time, Duration of clamping, Tumour size
P
patients with migraine, healthy controls
I/C
serum levels of 25-hydroxyvitamin D (25(OH)D), healthy controls
O
lower 25(OH)D concentration in patients with migraine
P
PD patients, healthy controls
I/C
O
prevalence of OH, pooled OR of OH with PD
P
24,406 participants
I/C
urinary metabolites of polycyclic aromatic hydrocarbons (OH-PAHs), highest versus lowest category of urinary naphthalene (NAP), fluorine (FLU), phenanthrene (PHEN), and total OH-PAH metabolites
O
odds of diabetes
P
elderly individuals
I/C
high-dose intermittent oral administration of vitamin D3, no intervention
O
serum 25(OH)D levels, fractures, falls, and mortality
P
ACUTE KIDNEY INJURY PATIENTS, NON-ACUTE KIDNEY INJURY CONTROLS
I/C
VITAMIN D STATUS, SERUM 25(OH)D LEVELS, SERUM 1,25(OH)2D LEVELS
O
MORTALITY
P
OHS patients
I/C
PAP treatment, control group
O
changes in arterial blood gases, sleep quality, polysomnography parameters, quality of life, total sleep time, sleep efficiency
P
patients with type 2 diabetes mellitus (T2DM)
I/C
sodium-glucose cotransporter-2 (SGLT2) inhibitors, control groups
O
orthostatic hypotension (OH)
P
elderly patients >65 years
I/C
laparoscopic hepatectomy (LH), open hepatectomy (OH)
O
postoperative complications, blood loss, length of stay, oncological safety